Antipsychotic Long-Acting Injectable (LAI) Adverse Effects, Mitigation Strategies, and Monitoring
Webcast
0.75 Contact Hours OVERVIEW
Antipsychotic Long-Acting Injectable (LAI) Adverse Effects, Mitigation Strategies, and Monitoring is organized by American Association of Psychiatric Pharmacists (AAPP).
Activity Dates: 05/31/2023 - 05/131/2026
Course Description
This webinar reviews the contraindications, warnings/precautions, common adverse effects, adverse effect mitigation strategies, and monitoring recommendations for LAI antipsychotics.
This is one of six modules in the Psychotropic LAI Training Program. Complete your complimentary registration now to access this module, 5 other ACPE approved modules, a LAI Pocket Guide, administration videos, and an Administrative Toolkit.
Learning Objectives:
- Describe contraindications, warnings/precautions, common adverse effects, and potential mitigation strategies for LAI antipsychotics.
- Discuss the management of anaphylaxis and hypersensitivity reactions.
- Outline a plan for assessing a patient pre-injection and immediately post-injection.
ACCREDITATION & CREDITS
Continuing Education Credit and Disclosures
ACPE Contact Hours: 0.75
ACPE Number: 0284-0000-23-024-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
TARGET AUDIENCE
NursingPharmacistHealthcare ProfessionalsNursesSPECIALITIES
Allergy and ImmunologyRELATED ONLINE COURSES
Quick Links